Research Articles
Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.
Article Title | Original Publication Date | Journal | Bone Marrow Disease |
---|---|---|---|
Paroxysmal nocturnal hemoglobinuria without GPI-anchor deficiency | Oct 2019 | The Journal of Clinical Investigation | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations | Dec 2023 | Journal of Blood Medicine | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs | Dec 2020 | Journal of Managed care and specialty pharmacy | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease | Dec 2020 | Journal of Managed care and specialty pharmacy | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology | Dec 2020 | Journal of Managed care and specialty pharmacy | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Paroxysmal nocturnal hemoglobinuria: Where are we going | May 2023 | American Journal of Hematology | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Paroxysmal nocturnal hemoglobinuria: Where we stand | May 2023 | American Journal of Hematology | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Parsing the Paradox of Myelodysplastic Syndromes | Dec 2020 | Journal of clinical oncology: official journal of the American Society Clinical Oncologysd | Myelodysplastic Syndromes (MDS) |
Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes | Jul 2020 | Leukemia Research | Myelodysplastic Syndromes (MDS) |
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. | Sep 2020 | PloS One | Paroxysmal Nocturnal Hemoglobinuria (PNH) |